PUBLICATIONS
研究論文
-
51. Aryal S, Hu CM, Zhang L Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Molecular pharmaceutics 8(4), 1401-1407 (2011) [JCR] [WOS] -
52. Lefkowitz RB, Marciniak JY, Hu CM, Schmid-Schonbein GW, Heller MJ An electrophoretic method for the detection of chymotrypsin and trypsin activity directly in whole blood. Electrophoresis 31(2), 403-410 (2010) [JCR] [WOS] -
53. Aryal S, Hu CM, Zhang L Combinatorial drug conjugation enables nanoparticle dual-drug delivery. Small 6(13), 1442-1448 (2010) [JCR] [WOS] -
54. Zhang L, Pornpattananangku D, Hu CM, Huang CM Development of nanoparticles for antimicrobial drug delivery. Current medicinal chemistry 17(6), 585-594 (2010) [JCR] [WOS] -
55. Hu CM, Kaushal S, Tran Cao HS, Aryal S, Sartor M, Esener S, Bouvet M, Zhang L Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Molecular pharmaceutics 7(3), 914-920 (2010) [JCR] [WOS] -
56. Hu CM, Aryal S, Zhang L Nanoparticle-assisted combination therapies for effective cancer treatment. Therapeutic delivery 1(2), 323-334 (2010) [JCR] [WOS] -
57. Aryal S, Hu CM, Zhang L Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS nano 4(1), 251-258 (2010) [JCR] [WOS] -
58. Fang RH, Aryal S, Hu CM, Zhang L Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir : the ACS journal of surfaces and colloids 26(22), 16958-16962 (2010) [JCR] [WOS] -
59. Hu CM, Zhang L Therapeutic nanoparticles to combat cancer drug resistance. Current drug metabolism 10(8), 836-841 (2009) [JCR] [WOS]
| Record 51 to 59, total of 59 records |